Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Achilles Therapeutics PLC (ADR - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ACHL
Nasdaq
8731
https://www.achillestx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Achilles Therapeutics PLC (ADR
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
- Apr 4th, 2024 10:45 am
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
- Apr 4th, 2024 10:30 am
Will Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?
- Mar 7th, 2024 3:18 pm
Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year?
- Feb 9th, 2024 2:40 pm
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
- Feb 5th, 2024 12:00 pm
Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?
- Jan 24th, 2024 2:40 pm
Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
- Dec 18th, 2023 12:00 pm
Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
- Nov 13th, 2023 9:30 pm
10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis
- Oct 24th, 2023 4:30 pm
Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans?
- Sep 29th, 2023 2:55 pm
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
- Sep 22nd, 2023 8:30 pm
Are Medical Stocks Lagging Achilles Therapeutics (ACHL) This Year?
- Sep 22nd, 2023 1:40 pm
Waters (WAT) Walk-Up Solutions Boost Bioprocess Development
- Sep 13th, 2023 4:05 pm
Is KalVista Pharmaceuticals (KALV) Stock Outpacing Its Medical Peers This Year?
- Sep 6th, 2023 1:40 pm
Jazz (JAZZ) Beats on Q2 Earnings & Sales, Raises '23 View
- Aug 10th, 2023 3:50 pm
Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
- Aug 4th, 2023 11:00 am
Achilles Therapeutics to Present at Upcoming Conferences
- Jun 12th, 2023 12:00 pm
3 Stocks With 1,000% Upside Potential
- May 21st, 2023 2:03 pm
Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
- May 10th, 2023 11:15 am
Achilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell Antigens
- May 10th, 2023 11:00 am
Scroll